Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Cheap, Simple Tests Could Improve Alzheimer’s Management at the Bedside

March 9, 2016 By Elsevier

Small, sensitive biosensors could help doctors deliver personalized care, even in developing countries

A portable biosensor that could show how disease is progressing in patients with Alzheimer’s could greatly improve people’s quality of life in the future, according to a new review published in Biosensors and Bioelectronics.

The authors of the review, from the Florida International University, are taking a new approach to diagnosing the disease: measuring the amount of a peptide called beta-amyloid in the blood with a cheap, quick, accurate point-of-care test. They hope their new approach will help patients, including those in developing countries, benefit from personalized treatment for Alzheimer’s disease.

Alzheimer’s disease is caused by high levels of beta-amyloid in the brain, which leads to the degeneration of brain cells. Doctors can use various types of scans and immunoassays, such as MRI and ELISA to estimate the amount of beta-amyloid in the brain, giving them an indication of how the disease is progressing. But the protein can also be found in lower levels in blood, making it a useful biomarker to diagnose and monitor disease progression.

Currently there is no sensitive or inexpensive way to measure beta-amyloid levels in the blood. The team behind the new review plans to change that.

“We want to develop a point of care system, where a small drop of blood plasma can reveal their beta-amyloid level immediately so that a doctor can tailor a patient’s therapy immediately,” explained Dr. Ajeet Kaushik, lead author of the review from the University of Florida. “The drugs used to treat Alzheimer’s disease can have side effects, so it’s better for patients not to overdose. With the right data, doctors can respond quickly to changes in a patient’s brain by reducing or increasing their dose.”

In the review, Dr. Kaushik and his colleagues looked at each of the methods available to measure beta-amyloid concentration in brain tissue and in blood. None of the existing tests can be done at the bedside and all need special expertise and large samples. They also take a long time to generate a useful result – the main existing test, called ELISA, takes six to eight hours.

In comparison, the cheap, simple biosensor Dr. Kaushik and colleagues describe can measure beta-amyloid in the blood at tiny concentrations in just half an hour.

“Even though existing technologies are well established, we need to move towards small sample, high accuracy tests that can be used in all environments, from developed countries to rural settings. Our goal is to develop a test that’s sensitive, small and affordable,” said Dr. Kaushik.

To develop the new biosensor the team will need lots of bio-fluid samples taken at different stages of the disease. Finding all the samples they need will be challenging, but the review demonstrates a biosensor is achievable in the future.

Dr. Kaushik concluded: “A quick biosensor test will enable a clinician to collect information on the progression of disease and see what’s happening to a patient over time. It will also show if and when the disease reaches an untreatable level. In the future we hope a rapid biosensor test for Alzheimer’s disease will help scientists study disease progression and help clinicians deliver personalized therapy to patients.”

Find more information on the study here.

Related Articles Read More >

A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
A photo of the miniature Auxilium Biotechnologies implants made on the International Space Station.
Implants 3D-printed in space could enable nerve regeneration
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe